XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2022
Jun. 30, 2021
Current assets    
Cash and cash equivalents $ 183 $ 319
Receivables, net 681 604
Inventories, net 755 752
Prepaid expenses and other current assets 106 154
Total current assets 1,725 1,829
Property, plant and equipment, net 1,334 1,302
Operating lease right-of-use assets 342 332
Goodwill 1,558 1,575
Trademarks, net 687 693
Other intangible assets, net 197 225
Other assets 315 378
Total assets 6,158 6,334
Current liabilities    
Notes and loans payable 237 0
Current maturities of long-term debt 0 300
Current operating lease liabilities 78 81
Accounts payable and accrued liabilities 1,469 1,675
Total current liabilities 1,784 2,056
Long-term debt 2,474 2,484
Long-term operating lease liabilities 314 301
Other liabilities 791 834
Deferred income taxes 66 67
Total liabilities 5,429 5,742
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2022 and 2021; and 123,152,132 and 122,780,220 shares outstanding as of June 30, 2022 and 2021, respectively 131 131
Additional paid-in capital 1,202 1,186
Retained earnings 1,048 1,036
Treasury stock, at cost: 7,589,329 and 7,961,241 shares as of June 30, 2022 and 2021, respectively (1,346) (1,396)
Accumulated other comprehensive net (loss) income (479) (546)
Total Clorox stockholders’ equity 556 411
Noncontrolling interests 173 181
Total stockholders’ equity 729 592
Total liabilities and stockholders’ equity $ 6,158 $ 6,334